Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Microbiol.

Sec. Microorganisms in Vertebrate Digestive Systems

This article is part of the Research TopicMicrobiome and its Roles in Disease Diagnosis and Treatment: Pathogen Resistance Spectrum, Metabolism, Risk Model, and Vaccine DesignView all 9 articles

Beyond Microbial Abundance: Metadata Integration Enhances Disease Prediction in Human Microbiome Studies

Provisionally accepted
Andre  R GoncalvesAndre R Goncalves*Hiranmayi  RanganathanHiranmayi RanganathanCamilo  ValdesCamilo ValdesHaonan  ZhuHaonan ZhuBoya  ZhangBoya ZhangCar Reen  KokCar Reen KokJose  Manuel MartiJose Manuel MartiNisha  J MulakkenNisha J MulakkenJames  ThissenJames ThissenCrystal  JaingCrystal JaingNicholas  A BeNicholas A Be*
  • Lawrence Livermore National Laboratory (DOE), Livermore, United States

The final, formatted version of the article will be published soon.

Multiple studies have highlighted interaction of the human microbiome with physiological systems such as the gut, immune, liver, and skin, via key axes. Advances in sequencing technologies and high-performance computing have enabled the analysis of large-scale metagenomic data, facilitating the use of machine learning to predict disease likelihood from microbiome profiles. However, challenges such as compositionality, high dimensionality, sparsity, and limited sample sizes have hindered the development of actionable models. One strategy to improve these models is by incorporating key metadata from both the human host and sample collection/processing protocols. This remains challenging due to sparsity and inconsistency in metadata annotation and availability. In this paper, we introduce a machine learning-based pipeline for predicting human disease states by integrating host and protocol metadata with microbiome abundance profiles from 68 different studies, processed through a consistent pipeline. Our findings indicate that metadata can enhance machine learning predictions, particularly at higher taxonomic ranks like Kingdom and Phylum, though this effect diminishes at lower ranks. Our study leverages a large collection of microbiome datasets comprising of 11,208 samples, therefore enhancing the robustness and statistical confidence of our findings. This work is a critical step toward utilizing microbiome and metadata for predicting diseases such as gastrointestinal infections, diabetes, cancer, and neurological disorders.

Keywords: Human microbiome, host disease prediction, machine learning, host metadata, Meta-analysis

Received: 01 Sep 2025; Accepted: 18 Nov 2025.

Copyright: © 2025 Goncalves, Ranganathan, Valdes, Zhu, Zhang, Kok, Marti, Mulakken, Thissen, Jaing and Be. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Andre R Goncalves, goncalves1@llnl.gov
Nicholas A Be, be1@llnl.gov

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.